FC
HELP

Fore Capital’s Helus Pharma Inc. Common Stock HELP Stock Holding History

Fore Capital’s Portfolio HELP Stock Details HELP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$241K Hold
36,421
– – 0.07% 59
2026
Q1 		$175K Sell
36,421
-30,000
-45% -$194K 0.11% 28
2025
Q4 		$543K Sell
66,421
-5,000
-7% -$32.2K 0.18% 40
2025
Q3 		$421K Buy
71,421
+40,000
+127% +$283K 0.12% 51
2025
Q2 		$264K Hold
31,421
– – 0.09% 33
2025
Q1 		$199K Hold
31,421
– – 0.12% 47
2024
Q4 		$277K Buy
31,421
+13,000
+71% +$132K 0.11% 44
2024
Q3 		$164K Buy
+18,421
New +$182K 0.07% 36

Other funds holding HELP

VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $269M AUM 103.38% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $767M AUM 119.71% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $366M AUM 474.6% 1-Year Est. Return
DA
DCF Advisers Greenwich, Connecticut $566M AUM 197.74% 1-Year Est. Return
SCM
Sio Capital Management New York $604M AUM 96.57% 1-Year Est. Return
NFGH
Nan Fung Group Holdings Kai Tak, Hong Kong $131M AUM 86.64% 1-Year Est. Return

Fore Capital's HELP Position: Q2 2026 in Review

Fore Capital held its Helus Pharma Inc. Common Stock (HELP) position steady in Q2 2026 at 36,421 shares worth $241K. The position accounts for 0.07% of the portfolio, ranked #59.

Fore Capital first reported a position in HELP in Q3 2024 and has held it in 8 quarters since. The position peaked at $543K in Q4 2025. 99 funds tracked by Wall St. Rank hold HELP as of Q2 2026.

  • Fore Capital held 36,421 shares of Helus Pharma Inc. Common Stock worth $241K as of Q2 2026.
  • Fore Capital left its Helus Pharma Inc. Common Stock share count unchanged in Q2 2026.
  • Helus Pharma Inc. Common Stock made up 0.07% of Fore Capital's portfolio in Q2 2026, its #59 holding.
  • Fore Capital first reported a position in Helus Pharma Inc. Common Stock in Q3 2024 and has held it in 8 quarters since.
  • Fore Capital's Helus Pharma Inc. Common Stock position peaked at $543K in Q4 2025.
  • 99 funds tracked by Wall St. Rank held Helus Pharma Inc. Common Stock as of Q2 2026.

Based on Fore Capital's 13F filing for Q2 2026, filed 10 Aug 2026.